Efficacy of Buscopan® in Comparison With 654-II (Anisodamine) in Acute Gastric or Intestinal Pain

Summary

The aim of the study is to assess the efficacy of Buscopan® (hyoscine butylbromide) in comparison to 654-II (anisodamine)in acute gastric or intestinal spasm-like pain.

Timeline

Start

2013-08

Primary completion

2015-02

Completion

2015-02

Outcome

Met primary endpoint

registry Buscopan® (Hyoscine Butylbromide) vs 654-II (Anisodamine); p <0.0001; Mean Difference (Final Values) -0.42 (95% CI -0.88 to 0.04) NCT01929044 ↗

Drugs

Indications